- Home
- ZTS
ZTS
Zoetis Inc.
as 11-20-2024 4:00pm EST
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
| Founded: | 1952 | Country: | United States |
| Employees: | N/A | City: | PARSIPPANY |
| Market Cap: | 82.8B | IPO Year: | 2013 |
| Target Price: | $219.50 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.32 | EPS Growth: | 8.38 |
| 52 Week Low/High: | $144.80 - $201.92 | Next Earning Date: | 11-04-2024 |
| Revenue: | $9,152,000,000 | Revenue Growth: | 9.33% |
| Revenue Growth (this year): | 9.19% | Revenue Growth (next year): | 5.35% |
Latest Zoetis Inc. News
ZTS Breaking Stock News: Dive into ZTS Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
Simply Wall St.
2 days ago
Is Zoetis Inc. (NYSE:ZTS) Trading At A 29% Discount?
Zacks
3 days ago
SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?
GuruFocus.com
8 days ago
Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc
Argus Research
8 days ago
Analyst Report: Zoetis Inc
Argus Research
8 days ago
Market Digest: HAL, ICE, NSC, MDLZ, ZTS, DKNG
Zacks
10 days ago
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Motley Fool
10 days ago
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
Compare ZTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZTS Zoetis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.